In end stage osteoarthritis, cartilage tissue pentosidine levels are inversely related to parameters of cartilage damage

Osteoarthritis and Cartilage

Volumn 20, Issue 3, 2012, Pages 233-240

  Vos, P A J M ^a,b   Mastbergen, S C ^a   Huisman, A M ^c   de Boer, T N ^a   DeGroot, J ^d   Polak, A A ^e   Lafeber, F P J G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

^c Sint Franciscus Gasthuis   (Netherlands)

^d TNO   (Netherlands)

^e Sint Fransciscus Gasthuis ^*  (Netherlands)

Author keywords

Advanced glycation endproducts; Cartilage; Knee replacement; Osteoarthritis; Pentosidine; Proteoglycan

Indexed keywords

ADVANCED GLYCATION END PRODUCT; PENTOSIDINE;

ADULT; AGED; ARTICLE; BIOMECHANICS; CARTILAGE CELL; CARTILAGE INJURY; CELL ACTIVITY; CHEMICAL ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; DISEASE PREDISPOSITION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JOINT SURGERY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OSTEOARTHRITIS; PRIORITY JOURNAL; TOTAL KNEE REPLACEMENT; URINALYSIS;

AGED; AGING; ARGININE; ARTHROPLASTY, REPLACEMENT, KNEE; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; COLLAGEN; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KNEE JOINT; LYSINE; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; SEVERITY OF ILLNESS INDEX;

EID: 84857140894     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2011.12.007     Document Type: Article

References (35)

1. Arden N., Nevitt M.C. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol 2006, 20:3-25.
2. Parsch D., Brummendorf T.H., Richter W., Fellenberg J. Replicative aging of human articular chondrocytes during ex vivo expansion. Arthritis Rheum 2002, 46:2911-2916.
3. DeGroot J. The AGE of the matrix: chemistry, consequence and cure. Curr Opin Pharmacol 2004, 4:301-305.
4. Verzijl N., DeGroot J., Thorpe S.R., Bank R.A., Shaw J.N., Lyons T.J., et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem 2000, 275:39027-39031.
5. Verzijl N., DeGroot J., Ben Z.C., Brau-Benjamin O., Maroudas A., Bank R.A., et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum 2002, 46:114-123.
6. Chen A.C., Temple M.M., Ng D.M., Verzijl N., DeGroot J., TeKoppele J.M., et al. Induction of advanced glycation end products and alterations of the tensile properties of articular cartilage. Arthritis Rheum 2002, 46:3212-3217.
7. Verbruggen G., Cornelissen M., Almqvist K.F., Wang L., Elewaut D., Broddelez C., et al. Influence of aging on the synthesis and morphology of the aggrecans synthesized by differentiated human articular chondrocytes. Osteoarthritis Cartilage 2000, 8:170-179.
8. DeGroot J., Verzijl N., Wenting-van Wijk M.J., Bank R.A., Lafeber F.P., Bijlsma J.W., et al. Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products. Arthritis Rheum 2001, 44:2562-2571.
9. Sell D.R., Monnier V.M. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem 1989, 264:21597-21602.
10. Steenvoorden M.M., Huizinga T.W., Verzijl N., Bank R.A., Ronday H.K., Luning H.A., et al. Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis Rheum 2006, 54:253-263.
11. Vos P.A., DeGroot J., Huisman A.M., Oostveen J.C., Marijnissen A.C., Bijlsma J.W., et al. Skin and urine pentosidine weakly correlate with joint damage in a cohort of patients with early signs of osteoarthritis (CHECK). Osteoarthritis Cartilage 2010, 18:1329-1336.
12. Matsumoto T., Tsurumoto T., Baba H., Osaki M., Enomoto H., Yonekura A., et al. Measurement of advanced glycation endproducts in skin of patients with rheumatoid arthritis, osteoarthritis, and dialysis-related spondyloarthropathy using non-invasive methods. Rheumatol Int 2007, 28:157-160.
13. Senolt L., Braun M., Olejarova M., Forejtova S., Gatterova J., Pavelka K. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein. Ann Rheum Dis 2005, 64:886-890.
14. Pavelka K., Forejtova S., Olejarova M., Gatterova J., Senolt L., Spacek P., et al. Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis. Osteoarthritis Cartilage 2004, 12:277-283.
15. Spacek P., Adam M. Pentosidine in osteoarthritis: HPLC determination in body fluids and in tissues. Rheumatol Int 2006, 26:923-927.
16. Hunter D.J., Lavalley M., Li J., Zhang Y., Bauer D., Nevitt M., et al. Urinary pentosidine does not predict cartilage loss among subjects with symptomatic knee OA: the BOKS Study. Osteoarthritis Cartilage 2007, 15:93-97.
17. Verzijl N., DeGroot J., Oldehinkel E., Bank R.A., Thorpe S.R., Baynes J.W., et al. Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem J 2000, 350(Pt 2):381-387.
18. Chang C.B., Seong S.C., Kim T.K. Evaluations of radiographic joint space-do they adequately predict cartilage conditions in the patellofemoral joint of the patients undergoing total knee arthroplasty for advanced knee osteoarthritis?. Osteoarthritis Cartilage 2008, 16:1160-1166.
19. Kijowski R., Blankenbaker D., Stanton P., Fine J., De Smet A. Arthroscopic validation of radiographic grading scales of osteoarthritis of the tibiofemoral joint. AJR Am J Roentgenol 2006, 187:794-799.
20. von Engelhardt L.V., Lahner M., Klussmann A., Bouillon B., David A., Haage P., et al. Arthroscopy vs. MRI for a detailed assessment of cartilage disease in osteoarthritis: diagnostic value of MRI in clinical practice. BMC Musculoskelet Disord 2010, 11:75.
21. Lafeber F.P., van der Kraan P.M., van Roy H.L., Vitters E.L., Huber-Bruning O., van den Berg W.B., et al. Local changes in proteoglycan synthesis during culture are different for normal and osteoarthritic cartilage. Am J Pathol 1992, 140:1421-1429.
22. Bank R.A., Krikken M., Beekman B., Stoop R., Maroudas A., Lafeber F.P., et al. A simplified measurement of degraded collagen in tissues: application in healthy, fibrillated and osteoarthritic cartilage. Matrix Biol 1997, 16:233-243.
23. Bank R.A., Jansen E.J., Beekman B., te Koppele J.M. Amino acid analysis by reverse-phase high-performance liquid chromatography: improved derivatization and detection conditions with 9-fluorenylmethyl chloroformate. Anal Biochem 1996, 240:167-176.
24. Kellgren J.H., Lawrence J.S. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957, 16:494-502.
25. de Boer T.N., Huisman A.M., Polak A.A., Niehoff A.G., van Rinsum A.C., Saris D., et al. The chondroprotective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment. Osteoarthritis Cartilage 2009, 17:482-488.
26. Lafeber F.P., Vander Kraan P.M., Huber-Bruning O., Vanden Berg W.B., Bijlsma J.W. Osteoarthritic human cartilage is more sensitive to transforming growth factor beta than is normal cartilage. Br J Rheumatol 1993, 32:281-286.
27. Whiteman P. The quantitative determination of glycosaminoglycans in urine with Alcian Blue 8GX. Biochem J 1973, 131:351-357.
28. Verzijl N., Bank R.A., TeKoppele J.M., DeGroot J. AGEing and osteoarthritis: a different perspective. Curr Opin Rheumatol 2003, 15:616-622.
29. Gibson G.J., Verner J.J., Nelson F.R., Lin D.L. Degradation of the cartilage collagen matrix associated with changes in chondrocytes in osteoarthrosis. Assessment by loss of background fluorescence and immunodetection of matrix components. J Orthop Res 2001, 19:33-42.
30. Verzijl N., DeGroot J., Bank R.A., Bayliss M.T., Bijlsma J.W., Lafeber F.P., et al. Age-related accumulation of the advanced glycation endproduct pentosidine in human articular cartilage aggrecan: the use of pentosidine levels as a quantitative measure of protein turnover. Matrix Biol 2001, 20:409-417.
31. Helfman P.M., Bada J.L. Aspartic acid racemization in tooth enamel from living humans. Proc Natl Acad Sci U S A 1975, 72:2891-2894.
32. DeGroot J., Verzijl N., Jacobs K.M., Budde M., Bank R.A., Bijlsma J.W., et al. Accumulation of advanced glycation endproducts reduces chondrocyte-mediated extracellular matrix turnover in human articular cartilage. Osteoarthritis Cartilage 2001, 9:720-726.
33. Anderson S.S., Tsilibary E.C., Charonis A.S. Nonenzymatic glycosylation-induced modifications of intact bovine kidney tubular basement membrane. J Clin Invest 1993, 92:3045-3052.
34. Bailey A.J., Paul R.G., Knott L. Mechanisms of maturation and ageing of collagen. Mech Ageing Dev 1998, 106:1-56.
35. DeGroot J., Verzijl N., Budde M., Bijlsma J.W., Lafeber F.P., TeKoppele J.M. Accumulation of advanced glycation end products decreases collagen turnover by bovine chondrocytes. Exp Cell Res 2001, 266:303-310.